MEDIFAST Price To Free Cash Flows Ratio from 2010 to 2024

MED Stock  USD 19.67  0.23  1.18%   
MEDIFAST INC's Price To Free Cash Flows Ratio is increasing over the years with slightly volatile fluctuation. Overall, Price To Free Cash Flows Ratio is expected to go to 5.44 this year. During the period from 2010 to 2024 MEDIFAST INC Price To Free Cash Flows Ratio annual values regression line had coefficient of variation of  98.95 and r-squared of  0.09. View All Fundamentals
 
Price To Free Cash Flows Ratio  
First Reported
2010-12-31
Previous Quarter
5.18241659
Current Value
5.44
Quarterly Volatility
13.80936133
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check MEDIFAST INC financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MEDIFAST INC's main balance sheet or income statement drivers, such as Depreciation And Amortization of 13.8 M, Interest Expense of 2.6 M or Selling General Administrative of 678.4 M, as well as many indicators such as Price To Sales Ratio of 0.65, Dividend Yield of 0.1 or PTB Ratio of 4.14. MEDIFAST financial statements analysis is a perfect complement when working with MEDIFAST INC Valuation or Volatility modules.
  
Check out the analysis of MEDIFAST INC Correlation against competitors.
For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.

Latest MEDIFAST INC's Price To Free Cash Flows Ratio Growth Pattern

Below is the plot of the Price To Free Cash Flows Ratio of MEDIFAST INC over the last few years. It is MEDIFAST INC's Price To Free Cash Flows Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in MEDIFAST INC's overall financial position and show how it may be relating to other accounts over time.
Price To Free Cash Flows Ratio10 Years Trend
Slightly volatile
   Price To Free Cash Flows Ratio   
       Timeline  

MEDIFAST Price To Free Cash Flows Ratio Regression Statistics

Arithmetic Mean13.96
Coefficient Of Variation98.95
Mean Deviation9.25
Median13.66
Standard Deviation13.81
Sample Variance190.70
Range63.5929
R-Value0.30
Mean Square Error187.44
R-Squared0.09
Significance0.28
Slope0.91
Total Sum of Squares2,670

MEDIFAST Price To Free Cash Flows Ratio History

2024 5.44
2023 5.18
2022 7.26
2021 40.63
2020 16.59
2019 17.38
2018 26.73

About MEDIFAST INC Financial Statements

MEDIFAST INC stakeholders use historical fundamental indicators, such as MEDIFAST INC's Price To Free Cash Flows Ratio, to determine how well the company is positioned to perform in the future. Although MEDIFAST INC investors may analyze each financial statement separately, they are all interrelated. For example, changes in MEDIFAST INC's assets and liabilities are reflected in the revenues and expenses on MEDIFAST INC's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in MEDIFAST INC. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Price To Free Cash Flows Ratio 5.18  5.44 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether MEDIFAST INC is a strong investment it is important to analyze MEDIFAST INC's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact MEDIFAST INC's future performance. For an informed investment choice regarding MEDIFAST Stock, refer to the following important reports:
Check out the analysis of MEDIFAST INC Correlation against competitors.
For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.
You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is Personal Care Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MEDIFAST INC. If investors know MEDIFAST will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MEDIFAST INC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.95)
Earnings Share
0.67
Revenue Per Share
61.769
Quarterly Revenue Growth
(0.41)
Return On Assets
0.0477
The market value of MEDIFAST INC is measured differently than its book value, which is the value of MEDIFAST that is recorded on the company's balance sheet. Investors also form their own opinion of MEDIFAST INC's value that differs from its market value or its book value, called intrinsic value, which is MEDIFAST INC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MEDIFAST INC's market value can be influenced by many factors that don't directly affect MEDIFAST INC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MEDIFAST INC's value and its price as these two are different measures arrived at by different means. Investors typically determine if MEDIFAST INC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MEDIFAST INC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.